Research & Expertise

Dr Gerwin Schalk is a professor at Fudan University in Shanghai and a partner of the HSE Centre for Language and Brain within the framework of the strategic project 'Human Brain Resilience.' Dr Schalk is known as the creator of BCI2000, a non-commercial general-purpose brain-computer interface system. In this interview, he discusses modern neural interfaces, methods for post-stroke rehabilitation, a novel approach to neurosurgery, and shares his vision for the future of neurotechnology.

The annual conference ‘ESG Corporate Dynamics: The Challenges for Emerging Capital Markets’ 2024 has been held at the School of Finance. The event brought together over 20 scholars from leading universities in China, Egypt, Malaysia, and other countries.

HSE University hosted a joint research seminar to review the 2024 results of the Strategic Project 'Human Brain Resilience: Neurocognitive Technologies for Adaptation, Learning, Development and Rehabilitation in a Changing Environment.' The event showcased the progress and outcomes of fundamental and applied projects focused on developing technologies for neurodiagnostics, neuroadaptation, and neurorehabilitation—collectively known as 3N technologies. The objective is to develop tools that can help prevent neurogenic and psychiatric disorders or alleviate their consequences.

In Russia, the annual cost of treating type 2 diabetes alone exceeds 500 billion roubles. Promoting healthy nutrition programmes can ease the burden on the healthcare system and increase life expectancy. This was the conclusion reached by economists at HSE University after analysing global experiences with government involvement in promoting a healthy lifestyle.

Scientists from HSE and Sechenov University have developed a methodology for identifying priority areas and breakthrough technologies to drive the pharmaceutical industry's development. Their joint research, supported by Innopraktika, aims to pinpoint key scientific directions crucial for addressing diseases with significant medical and social impact in the future. An analysis of current and projected data revealed that lung cancer, breast cancer, and stomach cancer contribute the most to the medical, social, and economic burden on healthcare systems. 

On November 29, the campus hosted the Expert Day of the HSE University-St Petersburg and University of Technology Malaysia mirror laboratory. The official partner of the event was the Our Future foundation.

Often, individuals with neurological or mental disorders exhibit distinctive language patterns. In modern clinical practice, digital tools can play a significant role in supporting language therapy and rehabilitation for persons with language disorders. Additionally, in the future, digital tools could assist healthcare specialists in assessing the severity of symptoms associated with such disorders.

Researchers at HSE University have developed a machine learning (ML) model capable of predicting the risk of complications—major adverse cardiac events—in patients following a myocardial infarction. For the first time, the model incorporates genetic data, enabling a more accurate assessment of the risk of long-term complications. The study has been published in Frontiers in Medicine.

A team of researchers at the HSE AI Research Centre has created an index to evaluate the ethical standards of artificial intelligence (AI) systems used in medicine. This tool is designed to minimise potential risks and promote safer development and implementation of AI technologies in medical practice.

Researchers at HSE University have proposed a novel approach to assessing AI's competency in educational settings. The approach is grounded in psychometric principles and has been empirically tested using the GPT-4 model. This marks the first step in evaluating the true readiness of generative models to serve as assistants for teachers or students. The results have been published in arXiv.